Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23731 AL 23745

Sex/gender differences in the clinical trajectory of Alzheimer's disease: Insights into diagnosis and cognitive reserve

Emrani S, Sundermann EE.

Front Neuroendocrinol. 2025 Apr;77:101184. doi: 10.1016/j.yfrne.2025.101184. Epub 2025 Feb 13.

Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches

Fatima G, Ashiquzzaman A, Kim SS, Kim YR, Kwon HS, Chung E.

Neurobiol Dis. 2025 May;208:106877. doi: 10.1016/j.nbd.2025.106877. Epub 2025 Mar 17.

Smartphone- and Tablet-Based Tools to Assess Cognition in Individuals With Preclinical Alzheimer Disease and Mild Cognitive Impairment: Scoping Review

van den Berg RL, van der Landen SM, Keijzer MJ, van Gils AM, van Dam M, Ziesemer KA, Jutten RJ, Harrison JE, de Boer C, van der Flier WM, Sikkes SA.

J Med Internet Res. 2025 May 27;27:e65297. doi: 10.2196/65297.

The Role of Periodontitis in Increasing Cognitive Decline in Alzheimer's Disease

Klonaris N, Murcia JDG, Patil S, Freitas CMT.

J Contemp Dent Pract. 2025 Mar 1;26(3):311-320. doi: 10.5005/jp-journals-10024-3847.

Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia

Magnussen JH.

Basic Clin Pharmacol Toxicol. 2025 Jul;137(1):e70061. doi: 10.1111/bcpt.70061.

Antiamyloid treatment for dementia: concerns outweigh hopes

Flicker L.

Curr Opin Psychiatry. 2025 Sep 1;38(5):355-360. doi: 10.1097/YCO.0000000000001021. Epub 2025 Jun 9.

Brexpiprazole for the Treatment of Agitation in Older Adults with Alzheimer's Disease: A Systematic Review, Bayesian Meta-analysis, and Meta-regression

da Silva AMP, Falcão L, Ribeiro Gonçalves O, Virgilio Ribeiro F, Machado Magalhães PL, Lee Han M, Łajczak P, Letícia de Bastos Maximiano M, Cal H, de Souza Franco E, de Sousa Maia MB.

CNS Drugs. 2025 Nov;39(11):1071-1082. doi: 10.1007/s40263-025-01219-y. Epub 2025 Aug 31.

Epileptic variant in the spectrum of Alzheimer's disease - practical implications

Cretin B.

Seizure. 2025 May;128:133-139. doi: 10.1016/j.seizure.2024.09.015. Epub 2024 Sep 21.

The impact of cognitive reserve relative to risk of Alzheimer's disease and rate of progression: an up-to-date review of the literature

Beveridge J, Sheth P, Thakkar S, Silverglate B, Grossberg G.

Expert Rev Neurother. 2025 Feb;25(2):175-187. doi: 10.1080/14737175.2024.2445015. Epub 2024 Dec 27.

The impact of sleep and exercise on brain atrophy in mild cognitive impairment

Mian M, Tahiri J, Habbal S, Aftan F, Reddy PH.

Mech Ageing Dev. 2025 Feb;223:112023. doi: 10.1016/j.mad.2024.112023. Epub 2024 Dec 26.

Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer's Disease

Ahlawat A, Walia V, Garg M.

Acta Neurol Belg. 2025 Aug;125(4):941-969. doi: 10.1007/s13760-024-02706-7. Epub 2025 Jan 7.

The role of lipid metabolism in cognitive impairment

Xu M, Wang L, Meng Y, Kang G, Jiang Q, Yan T, Che F.

Arq Neuropsiquiatr. 2025 Jan;83(1):1-13. doi: 10.1055/s-0044-1792097. Epub 2025 Jan 15.

Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer's Disease

Chen J, Zhu Z, Xu F, Dou B, Sheng Z, Xu Y.

Cells. 2025 Jan 22;14(3):164. doi: 10.3390/cells14030164.

Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD

Delbecque L, Elliott E, Cleanthous S, Heinrich P, Cano S, Wessels AM, Atkins AS.

J Prev Alzheimers Dis. 2025 Apr;12(4):100101. doi: 10.1016/j.tjpad.2025.100101. Epub 2025 Mar 4.

Nonamyloid-beta active immunization for the treatment of Alzheimer's disease

Triplett O, Varda N, Decourt B, Sabbagh MN.

Expert Opin Investig Drugs. 2025 Sep;34(9):685-693. doi: 10.1080/13543784.2025.2551352. Epub 2025 Sep 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias